R&D Accomplishments Molecular landscape of multi-step virus carcinogenesis revealed by multi-modal single-cell analysis

National Cancer Center Japan
Keio University School of Medicine
University of Miyazaki
Kyoto University
Japan Agency for Medical Research and Development

A joint research group led by Dr. Keisuke Kataoka at Keio University / National Cancer Center Japan has completed a comprehensive multi-modal single-cell analysis of the multicellular ecosystem in viral carcinogenesis by HTLV-1analyses, dissecting the cellular and molecular alterations of the peripheral blood in HTLV-1 infection, with and without progression to leukemia. Research was conducted together with Professor Seishi Ogawa of Kyoto University and Professor Kazuya Shimoda of the University of Miyazaki. The results of this research were published on the online edition of the American journal Blood Cancer Discovery on September 3, 2021.

The findings of this study are summarized as follows:

1. Our multi-modal single-cell analyses consist of single-cell simultaneous mRNA transcriptome, surface marker proteome, and T/B-cell receptor sequencing of 233,093 peripheral blood mononuclear cells from 30 ATL patients, 11 HTLV-1 asymptomatic carriers, and 4 healthy donors.HTLV-1 HBZ gene expression and single-cell TCR-seq clearly demarcate HTLV-1-infected nonmalignant cells from uninfected and malignant cells, enabling the precise characterization of the biological properties and phenotypic expressions of HTLV-1-infected cells for the first time.
2. Different sets of genes/molecules are upregulated at different stages, cooperating in malignant transformation. These include LGALS1 and CD99, whose functions were examined in vitro and/or in vivo, suggesting potential immunotherapy targets.
3. Single-cell TCR sequencing reveals the presence of clonally proliferating HTLV-1-infected premalignant CD4⁺ T cells, which are characterized by excessive MHC class II attenuation.
4. HTLV-1 infection and ATL development induce common and different changes in the immune microenvironment. Prominent changes are selective expansion of myeloid cells and reduction of B cells in ATL, pointing to their potential as therapeutic targets.
5. Single-cell data combined with a newly generated mouse model and in vitro co-culture analysis demonstrate that upregulated PD-L1 in CD274 structural variation-harboring tumors is transferred into nonmalignant microenvironmental cells. Notably, the transferred PD-L1 inhibited the proliferation of activated CD8⁺ T cells. These results suggest that genetically overexpressed PD-L1 in tumor cells serves as a major source of PD-L1 expression in the microenvironment, shedding light on the intricate mechanisms for evading anti-tumor immunity.

The results of this study manifest the potential of multi-modal single-cell analysis. They represent a major advance in understanding the genetic and biological basis of premalignant clonal expansion, multi-step viral carcinogenesis, and alterations of the immune microenvironment, with clinical implications.

This work was supported by the Japan Agency for Medical Research and Development (AMED; JP20wm0325013, JP19ck0106261, JP19ck0106254, JP20ck0106542, JP20ck0106538, and JP20cm0106575), Japan Society for the Promotion of Science (JSPS) KAKENHI (19K22573), National Cancer Center Research and Development Funds (31-A-4), the Takeda Science Foundation, the Naito Foundation, and the Japan Leukemia Research Fund.

For further information, please refer to the Japanese version of press release.

Title

Single-cell analysis of the multicellular ecosystem in viral carcinogenesis by HTLV-1

Authors

Junji Koya, Yuki Saito, Takuro Kameda, Yasunori Kogure, Mitsuhiro Yuasa, Joji Nagasaki, Marni B. McClure, Sumito Shingaki, Mariko Tabata, Yuki Tahira, Keiichi Akizuki, Ayako Kamiunten, Masaaki Sekine, Kotaro Shide, Yoko Kubuki, Tomonori Hidaka, Akira Kitanaka, Nobuaki Nakano, Atae Utsunomiya, Yosuke Togashi, Seishi Ogawa, Kazuya Shimoda, Keisuke Kataoka.

Publication

Blood Cancer Discovery

Research and development inquiries

Division of Molecular Oncology, National Cancer Center Research Institute
Junji Koya, M.D., Ph.D.
5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan
Telephone: +81-3-3542-2511
Email: jkoya"at"ncc.go.jp

Keio University School of Medicine, Department of Hematology
Professor Keisuke Kataoka, M.D., Ph.D.
Telephone: +81-3-5363-3785
E-mail: kekataok"at"keio.jp

Media inquiries

National Cancer Center
Office of Public Relations, Strategic Planning Bureau
5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan
E-mail: ncc-admin"at"ncc.go.jp

Keio University
Office of General Affairs, Keio University Shinanomachi Campus
35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan
E-mail: med-koho"at"adst.keio.ac.jp

University of Miyazaki
General Affairs Department, University of Miyazaki
1-1 Gakuen Kibanadai-nishi, Miyazaki 889-2192, Japan
E-mail: kouhou"at"of.miyazaki-u.ac.jp

Kyoto University
Global Communications Office
Yoshidahonmachi, Sakyo-ku, Kyoto 606-8317, Japan
E-mail: comms"at"mail2.adm.kyoto-u.ac.jp

AMED Research Program inquiries

Japan Agency for Medical Research and Development (AMED)
Division of Basic Medical Research, Department of Basic Medical Research
20F Yomiuri Shimbun Building, 1-7-1 Otemachi, Chiyoda-ku, Tokyo 100-0004, Japan
E-mail: jprogram"at"amed.go.jp

Replace "at" with "@".